Antonella Cusimano

1.7k total citations
35 papers, 1.2k citations indexed

About

Antonella Cusimano is a scholar working on Molecular Biology, Hepatology and Pharmacology. According to data from OpenAlex, Antonella Cusimano has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Hepatology and 6 papers in Pharmacology. Recurrent topics in Antonella Cusimano's work include Cancer Mechanisms and Therapy (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Antonella Cusimano is often cited by papers focused on Cancer Mechanisms and Therapy (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Antonella Cusimano collaborates with scholars based in Italy, United States and Canada. Antonella Cusimano's co-authors include Melchiorre Cervello, Giuseppe Montalto, Antonina Azzolina, James A. McCubrey, Giuseppa Augello, Nadia Lampiasi, Maria Rita Emma, Dimcho Bachvarov, Natale D’Alessandro and Monica Notarbartolo and has published in prestigious journals such as PLoS ONE, The FASEB Journal and FEBS Letters.

In The Last Decade

Antonella Cusimano

34 papers receiving 1.2k citations

Peers

Antonella Cusimano
Jui-Wen Huang Taiwan
Paul S. Jones United Kingdom
Giuseppa Augello Italy
Brice Sid Belgium
Xianzhong Ding United States
Shu‐Xiang Cui China
Siddhartha Kar United States
Dong Joon Kim China
Antonella Miglietta Italy
Ruiwen Zhang United States
Jui-Wen Huang Taiwan
Antonella Cusimano
Citations per year, relative to Antonella Cusimano Antonella Cusimano (= 1×) peers Jui-Wen Huang

Countries citing papers authored by Antonella Cusimano

Since Specialization
Citations

This map shows the geographic impact of Antonella Cusimano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Cusimano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Cusimano more than expected).

Fields of papers citing papers by Antonella Cusimano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Cusimano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Cusimano. The network helps show where Antonella Cusimano may publish in the future.

Co-authorship network of co-authors of Antonella Cusimano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Cusimano. A scholar is included among the top collaborators of Antonella Cusimano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Cusimano. Antonella Cusimano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cervello, Melchiorre, Giuseppa Augello, Lucio Cocco, et al.. (2024). The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH. Advances in Biological Regulation. 92. 101032–101032. 6 indexed citations
2.
Augello, Giuseppa, et al.. (2024). Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview. Cancers. 16(7). 1415–1415. 8 indexed citations
3.
Seidita, Aurelio, Maurizio Soresi, Lydia Giannitrapani, et al.. (2022). The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach. Frontiers in Nutrition. 9. 980429–980429. 23 indexed citations
4.
Borrello, María Teresa, Maria Rita Emma, Angela Listì, et al.. (2021). NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. The FASEB Journal. 35(3). e21395–e21395. 12 indexed citations
5.
Augello, Giuseppa, Maria Rita Emma, Antonina Azzolina, et al.. (2021). The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma. Cancer Letters. 519. 250–262. 12 indexed citations
6.
Cusimano, Antonella, Maurizio Soresi, Giuseppe Montalto, et al.. (2020). Hepatocellular Carcinoma: A Difficult Cancer to Treat. Critical Reviews™ in Oncogenesis. 26(2). 11–25. 2 indexed citations
7.
Augello, Giuseppa, Maria Rita Emma, Antonella Cusimano, et al.. (2020). The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment. Cells. 9(6). 1427–1427. 58 indexed citations
8.
Akula, Shaw M., Stephen L. Abrams, Linda S. Steelman, et al.. (2019). RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets. 23(11). 915–929. 71 indexed citations
9.
Tesauro, Diego, et al.. (2019). Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors. Amino Acids. 51(8). 1177–1185. 4 indexed citations
10.
Augello, Giuseppa, Martina Di Modica, Antonina Azzolina, et al.. (2018). Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells. Cell Death and Disease. 9(2). 28–28. 31 indexed citations
11.
Cusimano, Antonella, Antonina Azzolina, Giuseppa Augello, et al.. (2017). Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. International Journal of Oncology. 51(2). 533–544. 77 indexed citations
12.
Yang, Jing, Antonella Cusimano, Morgan Preziosi, et al.. (2015). WNT5A Inhibits Hepatocyte Proliferation and Concludes β-Catenin Signaling in Liver Regeneration. American Journal Of Pathology. 185(8). 2194–2205. 27 indexed citations
13.
Pullara, Filippo, Jennifer Guerrero‐Santoro, Monica Calero, et al.. (2012). A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. Protein Expression and Purification. 87(2). 111–119. 13 indexed citations
14.
Cusimano, Antonella, Antonina Azzolina, Juan Iovanna, et al.. (2010). Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. 9(7). 1399–1410. 36 indexed citations
15.
Cusimano, Antonella, Nadia Lampiasi, Antonina Azzolina, et al.. (2009). Prostaglandin E2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma. Annals of the New York Academy of Sciences. 1155(1). 300–308. 19 indexed citations
16.
Imbrici, Paola, Maria Cristina D’Adamo, Antonella Cusimano, & Mauro Pessia. (2006). Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvβ1.1. American Journal of Physiology-Cell Physiology. 292(2). C778–C787. 26 indexed citations
17.
Cusimano, Antonella, Maria Cristina D’Adamo, & Mauro Pessia. (2004). An episodic ataxia type‐1 mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+. FEBS Letters. 576(1-2). 237–244. 15 indexed citations
18.
Imbrici, Paola, Antonella Cusimano, Maria Cristina D’Adamo, Amalia De Curtis, & Mauro Pessia. (2003). Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels. Pflügers Archiv - European Journal of Physiology. 446(3). 373–379. 24 indexed citations
19.
Notarbartolo, Monica, Melchiorre Cervello, Luisa Dusonchet, Antonella Cusimano, & Natale D’Alessandro. (2002). Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Letters. 180(1). 91–101. 88 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jui-Wen Huang Breakdown of academic impact, for papers by Paul S. Jones Breakdown of academic impact, for papers by Giuseppa Augello Breakdown of academic impact, for papers by Brice Sid Breakdown of academic impact, for papers by Xianzhong Ding Breakdown of academic impact, for papers by Shu‐Xiang Cui Breakdown of academic impact, for papers by Siddhartha Kar Breakdown of academic impact, for papers by Dong Joon Kim Breakdown of academic impact, for papers by Antonella Miglietta Breakdown of academic impact, for papers by Ruiwen Zhang
Rankless by CCL
2026